Founderland Logofounderland
the ★ top ★ 100 ★ marketers ★
SavedSearch
FoundersFounders
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Product Launches
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Investment News
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Research & Innovation
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
FoundersFounders
Return

Company Page

Asgard Therapeutics

Founders

Fábio F. RosaFilipe Pereira

Asgard Therapeutics is a Swedish biotech company and spin-off from Lund University that develops off-the-shelf cancer immunotherapies based on direct cell reprogramming. Its proprietary TrojanDC gene therapy reprograms cancer cells into professional antigen-presenting dendritic cells, triggering a personalized immune response against tumors and overcoming limitations of conventional cell-based therapies.

Company Founded in 2018

Healthtech & Biotech iconHealthtech & Biotech

Articles about Asgard Therapeutics

Asgard Therapeutics raises $33M for in vivo cancer therapy

Asgard Therapeutics raises $33M for in vivo cancer therapy

Healthtech & Biotech iconHealthtech & BiotechOct 10, 2026

About

Dreamwell AIContact UsOur Story

Articles

Product LaunchesInvestment NewsResearch & Innovation

founderland

We Use Cookies

We baked up some cookies – the digital kind. They help Draper run like a well-oiled mid-century machine. Some are essential to the experience, others help us tailor things to your taste. We promise, no crumbs on your blazer. Take a moment to choose what works for you.